Authors:
Torn, C
Landin-Olsson, M
Lernmark, A
Schersten, B
Ostman, J
Arnqvist, HJ
Bjork, E
Blohme, G
Bolinder, J
Eriksson, J
Littorin, B
Nystrom, L
Sundkvist, G
Citation: C. Torn et al., Combinations of beta cell specific autoantibodies at diagnosis of diabetesin young adults reflects different courses of beta cell damage, AUTOIMMUN, 33(2), 2001, pp. 115-120
Authors:
Hedman, CA
Orre-Pettersson, AC
Lindstrom, T
Arnqvist, HJ
Citation: Ca. Hedman et al., Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes, CLIN ENDOCR, 55(1), 2001, pp. 107-112
Authors:
Littorin, B
Bjork, E
Sundkvist, G
Blohme, G
Nystrom, L
Bolinder, J
Carlson, A
Eriksson, JW
Landin-Olsson, M
Schersten, B
Ostman, J
Wibell, L
Arnqvist, HJ
Citation: B. Littorin et al., Family characteristics and life events before the onset of autoimmune type1 diabetes in young adults - A nationwide study, DIABET CARE, 24(6), 2001, pp. 1033-1037
Citation: Ca. Hedman et al., Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes, DIABET CARE, 24(6), 2001, pp. 1120-1121
Citation: B. Ekman et al., Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes, EUR J ENDOC, 143(4), 2000, pp. 505-510
Citation: T. Lindstrom et al., The use of human ultralente is limited by great intraindividual variability in overnight plasma insulin profiles, SC J CL INV, 60(5), 2000, pp. 341-347
Authors:
Torn, C
Landin-Olsson, M
Lernmark, A
Palmer, JP
Arnqvist, HJ
Blohme, G
Lithner, F
Littorin, B
Nystrom, L
Schersten, B
Sundkvist, G
Wibell, L
Ostman, J
Citation: C. Torn et al., Prognostic factors for the course of beta cell function in autoimmune diabetes, J CLIN END, 85(12), 2000, pp. 4619-4623
Citation: G. Dahlfors et Hj. Arnqvist, Vascular endothelial growth factor and transforming growth factor-beta 1 regulate the expression of insulin-like growth factor-binding protein-3,-4, and-5 in large vessel endothelial cells, ENDOCRINOL, 141(6), 2000, pp. 2062-2067
Authors:
Orre-Pettersson, AC
Lindstrom, T
Bergmark, V
Arnqvist, HJ
Citation: Ac. Orre-pettersson et al., The snack is critical for the blood glucose profile during treatment with regular insulin preprandially, J INTERN M, 245(1), 1999, pp. 41-45
Authors:
Landin-Olsson, M
Arnqvist, HJ
Blohme, G
Littorin, B
Lithner, F
Nystrom, L
Schersten, B
Sundkvist, G
Wibell, L
Ostman, J
Lernmark, A
Citation: M. Landin-olsson et al., Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus, AUTOIMMUN, 29(1), 1999, pp. 57-63
Authors:
Lindstrom, T
Nystrom, FH
Olsson, AG
Ottosson, AM
Arnqvist, HJ
Citation: T. Lindstrom et al., The lipoprotein profile differs during insulin treatment alone and combination therapy with insulin and sulphonylureas in patients with Type 2 diabetes mellitus, DIABET MED, 16(10), 1999, pp. 820-826
Authors:
Gustafsson, T
Andersson, P
Chen, T
Magnusson, JO
Arnqvist, HJ
Citation: T. Gustafsson et al., Interaction of angiotensin II and the insulin-like growth factor system invascular smooth muscle cells, AM J P-HEAR, 46(2), 1999, pp. H499-H507
Authors:
Littorin, B
Sundkvist, G
Hagopian, W
Landin-Olsson, M
Lernmark, A
Ostman, J
Arnqvist, HJ
Blohme, G
Bolinder, J
Eriksson, JW
Lithner, F
Schersten, B
Wibell, L
Citation: B. Littorin et al., Islet cell and glutamic acid decarboxylase antibodies present at diagnosisof diabetes predict the need for insulin treatment - A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes, DIABET CARE, 22(3), 1999, pp. 409-412
Authors:
Valdimarsson, T
Arnqvist, HJ
Toss, G
Jarnerot, G
Nystrom, F
Strom, M
Citation: T. Valdimarsson et al., Low circulating insulin-like growth factor I in coeliac disease and its relation to bone mineral density, SC J GASTR, 34(9), 1999, pp. 904-908
Citation: P. Andersson et al., Insulin-like growth factor binding proteins-2 to-6 are expressed by human vascular smooth muscle cells, J ENDOCR, 163(2), 1999, pp. 281-288
Citation: T. Gustafsson et al., Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells, J ENDOCR, 161(2), 1999, pp. 245-253